Last updated: 11/03/2018 22:27:31
A clinical study to evaluate the efficacy of three dry mouth relief products versus water
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Clinical Study to Evaluate the Efficacy of an Experimental Oralbalance Gel, Oral Rinse and Spray Versus Water
Trial description: This study assessed the efficacy of three dry mouth products (including an experimental Oralbalance gel, oral rinse, and moisturizing spray) to relieve the feeling of dry mouth compared to water, in dry mouth population over a period of 28 days.
Primary purpose:
Treatment
Trial design:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Allocation:
Randomized
Primary outcomes:
Modified Product Performance and Attributes Questionnaire I (PPAQ I) (Question Number 1: Relieving the discomfort of dry mouth)
Timeframe: At Day 29 of treatment (2 hours after supervised product use)
Secondary outcomes:
Modified Product Performance and Attributes Questionnaire I (PPAQ I) (Question Number 1:Relieving the discomfort of dry mouth ) at Day 29
Timeframe: At Day 29 of treatment (30 minutes, 1 hour and 4 hours after supervised product use)
Modified Product Performance and Attributes Questionnaire I (PPAQ I) Question Number 1: Relieving the discomfort of dry mouth) Day 1
Timeframe: At Day 1 of treatment (30 minutes, 1 hour, 2 and 4 hours after supervised product use)
Individual scores of all question from 2-12 of Modified Product Performance and Attributes Questionnaire I (PPAQ I)
Timeframe: At Day 1 and 29 (30 minutes, 1 hour, 2 and 4 hours after supervised product use)
Individual scores for all questions of Modified Product Performance and Attributes Questionnaire I (PPAQ I) at Day 8
Timeframe: At Day 8 (2 hours after supervised product use)
Individual questions scores of Modified Product Performance and Attributes Questionnaire II (PPAQ II)
Timeframe: At Day 8 and 29
Area Under curve (AUC) up to 4 hours after treatment- response of all question of the modified Product Performance and Attributes Questionnaire I (PPAQ I)
Timeframe: At Day 1 and 29
Interventions:
Enrollment:
422
Primary completion date:
2014-10-01
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Not applicable
Medical condition
Xerostomia
Product
sodium fluoride
Collaborators
Not applicable
Study date(s)
September 2013 to January 2014
Type
Interventional
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
35 - 84 years
Accepts healthy volunteers
Yes
- Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
- Understands and is willing, able and likely to comply with all study procedures and restrictions.
- Women who are known to be pregnant or who are intending to become pregnant over the duration of the study.
- Women who are breast–feeding.
Inclusion and exclusion criteria
Inclusion criteria:
- Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
- Understands and is willing, able and likely to comply with all study procedures and restrictions.
- Good general and mental health with, in the opinion of the investigator or medically qualified designee: a) No clinically significant and relevant abnormalities of medical history or oral examination., b) Absence of any condition that would impact on the subject’s safety or wellbeing or affect the individual’s ability to understand and follow study procedures and requirements. Subjects with stable and controlled medical conditions with no overt medical conditions which would contraindicate participation (in the opinion of the Investigator or medically qualified designee) which would interfere with the conduct of the study.
- Self reported feeling of a dry mouth according to the modified DMI questions. Subject must answer at least 3 out of 5 questions with ‘agree a little’, ‘agree’ or ‘strongly agree’.
Exclusion criteria:
- Women who are known to be pregnant or who are intending to become pregnant over the duration of the study.
- Women who are breast–feeding.
- Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.
- Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit.
- Previous participation in this study.
- Recent history (within the last 1 year) of alcohol or other substance abuse.
- An employee of the sponsor or the study site or members of their immediate family.
- Subject works in one of the following: Advertising, Journalism, Public Relations, Manufacturing, retail or distribution of medicines, medical devices or healthcare products, Market Research or Marketing.
- Use of prescription systemic parasympathetic medications (e.g. Pilocarpine), for the treatment of the feeling of dry mouth.
- At the discretion of the examiner, subjects currently under the care of a dental/medical professional specifically for the treatment of dry mouth.
- Evidence of gross intra-oral neglect or need for extensive dental therapy.
- Denture wearer (partial or complete dentures).
- Subject with dental implants.
- Subjects with untreated oral mucosal disease which in the opinion of the investigator could interfere with the study (e.g. current oral ulceration).
- Subject is currently undergoing radiotherapy and/or chemotherapy treatment.
- Any condition the investigator identifies that can confound the subject’s ability to properly participate in the study e.g. Alzheimer’s Disease.
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Statistical analysis plan
Available language(s): English
Clinical study report
Available language(s): English
Protocol
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Results posted on ClinicalTrials.gov
Recruitment status
Study complete
Actual primary completion date
2014-10-01
Actual study completion date
2014-10-01
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Additional information
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website